XML 28 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 962 $ 1,805
Trade receivables - third party and affiliates 1,121 1,243
Non-trade receivables, net 493 541
Inventories 2,284 2,357
Other assets 285 272
Total current assets 5,145 6,218
Investments in affiliates 1,217 1,220
Property, plant and equipment (net of accumulated depreciation - 2024: $4,562; 2023: $4,080) 5,273 5,584
Operating lease right-of-use assets 388 422
Deferred income taxes 1,251 1,677
Other assets 555 524
Goodwill [1] 5,387 6,977
Intangible assets, net 3,641 3,975
Total assets 22,857 26,597
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 1,501 1,383
Trade payables - third party and affiliates 1,228 1,510
Other liabilities 1,120 1,154
Income taxes payable 4 25
Total current liabilities 3,853 4,072
Long-term debt, net of unamortized deferred financing costs 11,078 12,301
Deferred income taxes 933 999
Uncertain tax positions 286 300
Benefit obligations 396 457
Operating lease liabilities 294 325
Other liabilities 408 591
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2024 and 2023: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2024: 170,827,196 issued and 109,327,556 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding) 0 0
Treasury stock, at cost (2024: 61,499,640 shares; 2023: 61,570,314 shares) (5,486) (5,488)
Additional paid-in capital 409 394
Retained earnings 11,100 12,929
Accumulated other comprehensive income (loss), net (848) (744)
Total Celanese Corporation shareholders' equity 5,175 7,091
Noncontrolling interests 434 461
Total equity 5,609 7,552
Total liabilities and equity $ 22,857 $ 26,597
[1] Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment as of December 31, 2024. There were no accumulated impairment losses as of December 31, 2023.